Education
About Us
Working with TipRanks
Follow Us
XBiotech (XBIT)
NASDAQ:XBIT
XBIT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.50 - $8.32
Previous CloseN/A
Volume27.99K
Average Volume (3M)57.22K
Market Cap
$83.84M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.29
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Jul 15, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)-1.26
Shares Outstanding30,487,732
10 Day Avg. Volume72,795
30 Day Avg. Volume57,220
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
XBiotech News
XBIT FAQ
What was XBiotech’s price range in the past 12 months?
XBiotech lowest stock price was $2.50 and its highest was $8.32 in the past 12 months.
What is XBiotech’s market cap?
XBiotech’s market cap is $83.84M.
When is XBiotech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were XBiotech’s earnings last quarter?
Currently, no data Available
Is XBiotech overvalued?
According to Wall Street analysts XBiotech’s price is currently Overvalued.
Does XBiotech pay dividends?
XBiotech pays a Notavailable dividend of $2.47 which represents an annual dividend yield of N/A. See more information on XBiotech dividends here
What is XBiotech’s EPS estimate?
XBiotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does XBiotech have?
XBiotech has 30,487,732 shares outstanding.
What happened to XBiotech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of XBiotech?
Among the largest hedge funds holding XBiotech’s share is Caxton Associates LP. It holds XBiotech’s shares valued at 0.
XBiotech Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 6.4%
Last 30 Days ▼ 6.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.14%
12-Months-Change
Fundamentals
Return on Equity
-15.23%
Trailing 12-Months
Asset Growth
-17.11%
Trailing 12-Months
Company Description
XBiotech
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Technical Analysis
Alterity Therapeutics
―
Immunic
―
Nautilus Biotechnolgy
―
Acumen Pharmaceuticals
―
Invivyd
―
Ownership Overview
12.54%
Insiders
5.40% Mutual Funds
1.16% Other Institutional Investors
77.82% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---